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8INTRODUCTION
Cerebrovascular diseases, of late has emerged as one of the 
leading contributors to the morbidity and mortality of our nation’s 
population. Although it has a specific age predilection, in that being 
common among the elderly, it does not spare the young too in 
whom the effects are more dramatic, as a hale and hearty 
individual becomes nothing but a vegetable in an instant. It 
manifests as an abrupt onset of focal neurological deficits as if the 
patient has been “struck by the hand of God”.
The morbidity the cerebrovascular disease causes is equal in 
effect to its mortality, as the functional recovery of the patient 
cannot be guaranteed. In this modern era of medicine, an effective 
cure for this disease is still elusive. It becomes therefore 
mandatory on the part of the treating physicians to alleviate the 
suffering of the patient, as much as possible.
The causes of stroke are many since it depends on the 
interplay of multiple factors present in the patient. The patient may 
present with arterial or venous stroke, ischemic or haemorrhagic 
stroke, anterior circulation or posterior circulation stroke. Thus, the 
combination of the factors, leads to a varied etiological, 
9pathological and clinical presentation which in the end leave a trail 
of devastation in the patient’s life.
The patient who presents with acute cerebrovascular 
disease is traditionally evaluated to determine the extent of the 
involvement of the higher mental functions, cranial nerves, motor 
system, sensory system, extrapyramidal system and cerebellar 
functions. Autonomic function testing is usually not given its due 
importance. This is because of the complex nature of the 
autonomic function tests and the relative technical difficulty faced 
in administering the test to the patients.
A certain level of cooperation from the patient and a 
degree of mobility of the patient is definitely required to carry out 
the autonomic functions. As this is not usually possible in these 
bed ridden patients, a newer method to assess the autonomic 
dysfunction becomes mandatory. This role is well fulfilled by the 
simple and non-invasive measurement of resting heart rate 
variability. The measurement of heart rate variability in the resting 
state has been well documented to correlate with the findings of 
other autonomic function tests and can be useful as a single test 
instead of a battery of tests in patients where it is not possible to 
carry out such investigations.
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The problem of autonomic dysfunction in patients with 
acute cerebrovascular diseases is still not given adequate 
importance as the mechanisms behind such dysfunction are still 
unclear. Newer models of cerebrocardiac interactions and the role 
of the insular cortex in maintaining the sympathovagal balance on 
the heart are being evolved and animal studies have provided 
newer insights. However the clinical implications of autonomic 
dysfunction have been well studied and documented in patients 
who have survived. It has been found to correlate well the 
morbidity and mortality of such patients. The effect of autonomic 
dysfunction on mortality and morbidity of patients with acute 
myocardial infarction and heart failure have been well established 
and the benefits of beta blockers have improved outcomes in 
these patients.
So the presence of autonomic dysfunction may play a 
role in the development of cardiac arrhythmias in patients with 
stroke and interventions directed towards reducing the incidence 
of it may play a role albeit in decreasing the morbidity as well as 
mortality associated with cerebrovascular diseases.
11
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AIM
The present study was carried out to assess the status of the 
autonomic function in patients with a clinical diagnosis of acute 
cerebrovascular disease in a tertiary care setting and determine its 
influence on the morbidity and mortality.
OBJECTIVES
Primary Objective
To assess the status of autonomic function of patients 
when admitted to the Rajiv Gandhi Government General 
hospital, Chennai, a tertiary care referral hospital in the 
public sector which caters to the needs of the population of 
Tamilnadu as well as those from neighboring stateswith a 
clinical diagnosis of acute cerebrovascular disease.
Secondary Objectives
a) To assess the predictive value of autonomic 
dysfunction (if any) on the morbidity and mortality of 
patients with a clinical diagnosis of acute 
cerebrovascular disease
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b) To identify potential areas of interventions that can 
improve the long term outcome in patients with a 
clinical diagnosis of acute cerebrovascular disease
14
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REVIEW OF LITERATURE
DEFINITION
A stroke, or cerebrovascular accident, had been defined 
as the abrupt onset of a neurological deficit that is attributable to a 
focal vascular cause1. Thus, the definition of stroke is clinical, and 
the laboratory studies, including imaging studies, are used to 
support the diagnosis and not to make it.
WHO had defined stroke as a “rapidly developed clinical 
signs of focal disturbance of cerebral function, lasting more than 
24 hours or leading to death, with no apparent cause other than 
vascular origin”.
The disturbance of the cerebral function could be caused 
by either of three major morphological abnormalities, i.e. stenosis, 
occlusion or rupture of the arteries or a combination of these three 
morphological abnormalities. Its manifestation therefore depends 
on the extent and site of the area involved as well as the 
underlying causes and might take the form of coma, hemiplegia, 
paraplegia, monoplegia, speech disturbances, cranial nerve 
paresis, sensory impairment, vertigo, or gait disturbances.
17
EPIDEMIOLOGY
Cerebrovascular disease has emerged as the third most 
common cause of death worldwide, after coronary heart disease 
and cancer2. Although the exact prevalence of cerebrovascular 
disease has not yet been estimated in India, the age standardized 
mortality rate for non-communicable diseases in India for the year 
2008 had been estimated as 685 per 100,000 population2. 
The first epidemiological survey on stroke carried out by 
Abraham and co-workers in Vellore, Tamilnadu, indicated that the 
prevalence of stroke to be 52 per 100,000 population (in which 
cohort)3. However, studies carried out later in various regions of 
the country estimated the prevalence to range from 44 to 220 per 
100,000 population4, 5, 6, 7.
It had been estimated that stroke contributes to 1.2 % of 
the total deaths in India, when all ages were included. The 
proportion of stroke death increased with age, and in the oldest 
group (> 70 years of age) stroke contributed to as high as 2.4% of 
all deaths8. 
In 2005, estimates indicated that 58 million people died 
worldwide, and in them chronic diseases accounted for 35 million 
deaths (60%). Cardiovascular diseases, predominantly heart 
disease and stroke, were the cause of death in 17.5 million 
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individuals. After heart disease, stroke is the second leading single 
cause of death, with 5.8 million fatal cases per year, 40% of which 
are in people younger than 70 years9.
Asians have a lower rate of coronary heart disease and a 
higher prevalence of stroke. Among the Asians, the number who 
died from stroke was more than three times that for coronary heart 
disease. The disparity between the incidence rates for stroke and 
coronary heart disease had been attributed to high prevalence of 
hypertension and low levels of blood lipids among the Orientals10. 
Hypertension was related to high salt intake and perhaps to 
genetic factors and low serum lipid was due to low levels of animal 
fats and protein in the oriental diet. However, detailed 
epidemiological data and the annual incidence rate of stroke in 
India is still lacking due to the absence of a strong surveillance 
system in India.
AUTONOMIC NERVOUS SYSTEM
The autonomic nervous system is that part of the 
peripheral nervous system that acts as a control system 
functioning largely below the level of consciousness, and controls 
visceral functions. It is classically divided into two subsystems: the 
parasympathetic nervous system and the sympathetic nervous 
system. The sympathetic division has thoracolumbar “outflow”, 
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meaning that the neurons begin at the thoracic and lumbar (T1-L2) 
segments of the spinal cord. The parasympathetic division has 
craniosacral “outflow”, meaning that the neurons begin at the 
cranial nerves (CN 3, CN7, CN 9, and CN10) and sacral (S2-S4)
segments of the spinal cord.
CEREBROCARDIAC INTERACTION
The concept of central integration in cardiac and vascular 
regulation can be better understood by knowing that any increase 
in blood pressure and cardiac output increases the activity of the 
afferent pathway, which reflexively inhibits sympathetic activity or 
activates parasympathetic activity or both. However, any decrease 
in blood pressure and cardiac output decreases afferent activity, 
which reflexively increases excitatory responses. Thus, 
cardiovascular function is controlled by a negative-feedback 
system, and increasing activity of the afferent pathway results in 
decreasing activity of the sympathetic efferent pathway and/or 
increasing activity of the parasympathetic efferent pathway and 
vice versa11. 
In the afferent pathways, arterial baroreceptors located in 
the carotid sinus, aortic arch, and various thoracic arteries respond 
to changes in blood pressure and give rise to afferent activity, 
which conducts in the glossopharyngeal and vagus nerves. The 
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cardiac mechanoreceptors are sensitive to mechanical 
deformation of the cardiac chambers and gives rise to afferent 
activity, which conducts in the vagus nerve. The pulmonary stretch 
receptors are sensitive to lung volumes, and inhalation increases 
afferent activity, which conducts in the vagus nerve11.
In the efferent pathways, the sympathetic nervous system 
(SNS) is predominantly involved in cardiac and vascular 
regulation, and the parasympathetic nervous system (PNS) only 
has a little influence on the peripheral vasculature. Postganglionic 
sympathetic fibers innervate the atria, the ventricles, and coronary 
arteries from the cervical ganglia as the superior, middle, and 
inferior cardiac nerves or from thoracic ganglia at the T1-T4 level. 
Stimulation causes increased heart rate, increased myocardial 
contractility, and coronary vasodilatation11. 
Postganglionic sympathetic fibers innervate the 
vasculature from plexus on the large proximal vessels or from the 
somatic nerve. The innervation is denser in resistance vessels 
(small arteries and large arterioles) than in capacitance vessels 
(venules and veins). A balance of alpha adrenergic 
(vasoconstricting) and beta adrenergic (vasodilating) innervation
exists. Preganglionic parasympathetic fibres innervate the atria, 
the ventricles, and coronary arteries from the vagus either by the 
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superior and middle cardiac rami or by the recurrent laryngeal 
nerve as the inferior cardiac rami. Stimulation causes decreased 
heart rate, coronary vasoconstriction and decreased contractility11.
The central autonomic network is a complex network in 
the central nervous system that integrates and regulates 
autonomic function. The network involves the cerebral cortex (the 
insular and medial prefrontal regions), amygdala, striaterminalis, 
hypothalamus, and brainstem centers (periaqueductal gray, 
parabrachial pons, nucleus of the tractussolitarius, and 
intermediate reticular zone of the medulla)11. 
It has been well established that hemispheric lesions 
altering the wide spread central autonomic network may impair the 
baroreflex function12. Baroreflex dysfunction had been said to play 
a role in hypertension, coronary artery disease, myocardial 
infarction, and chronic heart failure. Baroreflex impairment in 
conjunction with reduced vagal inhibitory outflow results in chronic 
activation of the sympathetic nervous system. A sustained 
increase in sympathetic activity contributes to end-organ damage 
and to disease progression and may predispose to subsequent 
cardiovascular events. It is clinically important to note that 
impaired cardiac baroreceptor reflex sensitivity has been shown to 
independently predict mortality and the incidence of adverse 
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cardiovascular events in hypertension or after myocardial 
infarction and had been associated with a poor prognosis in 
chronic heart failure13, 14.
Disease manifestations that indicate baroreceptor reflex 
dysfunction, such as hypertensive crises or high blood pressure 
variability, often accompany the acute phase of ischemic or 
haemorrhagic stroke15. It had been shown consistently that the 
impairment of baroreflex is present in patients with acute ischemic 
and haemorrhagic stroke12, 15, 16, 17. The level of baroreflex 
dysfunction did not differ between ischemic stroke and 
intracerebral haemorrhage, albeit different mechanisms could be 
anticipated18. Underlying pathophysiologic mechanisms are 
generally unknown; however, there is increasing evidence that the 
central autonomic network is involved. The insular cortex plays a 
principal role in modulating baroreflex sensitivity19, 20, 21. The 
baroreflex sensitivity was found to be impaired in stroke patients 
with left and/or right insular involvement compared with patients 
without insular involvement or control subjects17. This finding 
suggests that both insulae may participate in the regulation of 
baroreflex. Both the left and right insulae have been previously 
suggested to modulate baroreflex sensitivity19, 20, 21, 22. The 
baroreflex-related neuronal interconnections have been observed 
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between the right and left insulae, suggesting that both the insulae 
probably interact in integrating circulatory control information23.
Controversy exists on the topic of proposed hemispheric 
lateralization of the baroreflex and/or autonomic control. Sykora 
and co-workers showed that lesions involving the area of left 
insula decreased baroreflex sensitivity significantly more than 
lesions of right insula24. Similar findings were demonstrated by Hilz 
et al, who showed a decrease in baroreflex sensitivity in 
conjunction with left-sided hemispheric inactivation in epilepsy 
patients25. Studies carried out by Zamirini et al and Oppenheimer 
et al showed right-sided dominance of sympathetic and left-sided 
dominance of parasympathetic modulation26,27.
On the other hand, studies carried out by Naver et al and 
Meyer et al indicated that in patients with ischemic stroke, there is 
a reduction in parasympathetic and an increase in sympathetic 
heart rate modulation with right sided strokes28,29. At this point of 
time, it is not clear whether the right or left insula control central 
autonomic function. 
The investigation of baroreflex changes in patients with 
acute cerebrovascular diseases represents a technical and 
methodological challenge. This is because the disease is 
frequently associated with carotid atherosclerosis, heart failure, 
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coronary artery disease, a history of hypertension, and previous 
antihypertensive treatment. These conditions are well known to 
alter the baroreflex function and hence revealing the true aetiology 
of stroke related baroreflex changes is complex30. In the study by 
Sykora et al, the impairment of baroreflex was seen in patients 
with acute cerebrovascular diseases and this was seen to be 
independent of carotid artery atherosclerosis. They also observed 
that there was decreased baroreflex function in stroke patients 
compared with controls matched for atherosclerosis and other 
possible confounding factors, which were attributed to lesions 
affecting central autonomic regions31. 
Factors like age, heart failure, coronary artery disease, 
diabetes mellitus, history of hypertension and previous 
antihypertensive treatment represent confounders for the 
assessment of baroreflex sensitivity in acute stroke. Hence, earlier 
studies examining baroreflex sensitivity in acute stroke excluded 
patients with heart failure, coronary artery disease, and a history of 
myocardial infarction or diabetes to prevent bias. However, Sykora 
et al found no statistical significant influence when tested for this. 
The effects of age and hypertension on baroreflex sensitivity, 
albeit not significant, were seen in the control group. They 
hypothesized that these effects were also present in the stroke 
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group but were presumably outweighed by stroke-related changes 
in baroreflex sensitivity31.
Patients presenting with a shift in autonomic balance 
were found to be at increased risk for developing cardiac 
complications and demonstrated a significantly higher 
cardiovascular morbidity and mortality32, 33, 34.The possible 
pathophysiologic mechanisms which can be associated with this 
high risk include raised arrhythmogenic potential, increased 
platelet aggregability, coronary vasoconstriction and impaired 
ventricular remodelling, which are all known to be associated with 
increased sympathetic activity.
Laowattana et al found that left insular stroke was 
associated with a significantly adverse long term cardiac outcome, 
particularly in patients without coronary artery disease35. They 
proposed that there is involvement of the baroreflex arch with 
decreased parasympathetic tone and increased sympathetic drive 
in these patients which were responsible for the adverse 
outcomes. Other manifestations of autonomic dysfunction after 
insular stroke include disturbed circadian blood pressure patterns, 
higher norepinephrine levels, cardiac arrhythmias or QT 
prolongation which can explain the various interplaying 
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mechanisms that contribute to the adverse outcome in these 
patients36, 37.
CLINICAL IMPLICATIONS
Acute cerebrovascular disease is associated with an 
adverse long term cardiac outlook which is possibly relating to 
altered sympathovagal balance38. Barron et al have reported that 
when compared with age/gender matched controls, the total 
spectral power of RR intervals was reduced after an episode of 
acute cerebrovascular disease. The power associated with cardiac 
parasympathetic neural activity was particularly affected indicating 
a shift in the sympathovagal balance39. Strittmatter et al and 
Giubilei et al also reported elevation of the sympathetic cardiac 
tone in the acute phase of stroke and this was found to persist 
upto three weeks40,41. 
Sander et al have reported that the absence of circadian 
cardiovascular variation was particularly striking after insular 
infarction. In these patients, the plasma noradrenaline levels were 
higher. Also an elevated nocturnal blood pressure, a higher 
incidence of QTc interval prolongation and ventricular arrhythmias 
was demonstrable when compared to patients with stroke in other 
locations42, 43,44. 
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Wolf et al first reported on the association between 
reduced heart rate variability and higher post infarction mortality, 
sudden cardiac death, and arrhythmias in patients recovering from 
acute myocardial infarction45. In neurologic conditions, heart rate 
variability has been studied in patients with diabetic neuropathy, 
spinal cord injury and brain death46, 47, 48, 49, 50. A study of heart rate 
variability in children with head trauma showed a significant 
decrease in the low frequency / high frequency (LF/HF) ratio 
among patients with high intracranial pressure and reduced 
cerebral perfusion pressure and those who progressed to brain 
death51. In a study of 29 neurosurgical patients treated in an 
intensive care unit, poor recovery and death were associated with 
reduction of total power of HRV, power in VLF and LF bands, and 
decreased LF/HF ratio52.
Few studies have addressed heart rate variability in the 
context of acute stroke.  Kawecka et al reported a decrease in the 
heart rate variability among 36 patients with acute stroke (ischemic 
and haemorrhagic) and hypertension, compared with age-matched 
control subjects with hypertension53. Meglic et al evaluated heart 
rate variability in 14 patients with acute brainstem strokes and 
compared the profiles in medullary and non-medullary strokes. 
The integrals over HF and LF spectral bands were significantly 
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smaller in patients with medullary strokes, whereas those with 
non-medullary strokes had HRV profiles similar to controls, 
suggesting the occurrence of autonomic dysfunction in medullary 
stroke54. Tokgozoglu et al studied the heart rate variability profiles 
of 62 patients with ischemic stroke and 62 controls. All patients 
with stroke had significantly decreased power in LF and HF bands. 
However, patients with right-middle cerebral artery and insular 
infarcts had significantly lower power compared with all other 
localizations suggesting a possible selective influence of these 
regions of the brain over cardiac autonomic function55. 
Sykora et al hypothesized that autonomic dysfunction in 
acute stroke as expressed by decreased baroreflex sensitivity may 
have effects on outcome in the following ways: 
a) Inadequate cerebral perfusion due to the increased 
blood pressure variability and impaired cerebral auto 
regulation
b) Increased cardiovascular complications
c) Secondary brain injury due to inflammation, 
hyperglycemia, and blood– brain barrier disruption24.
The knowledge about baroreflex dysfunction in acute 
cerebrovascular diseases raised questions regarding the 
therapeutic implications of this finding. Baroreflex sensitivity can 
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be positively influenced by certain drugs, especially beta 
blockers56,57. Loawattana et al showed that among 111 ischemic 
stroke patients, the use of beta blockers was independently 
associated with less severe stroke on presentation and that 
sympatholytic effects may have cerebroprotective properties58. In 
an animal model, beta blockers given before the induction of 
experimental ischemia led to a reduction in infarct volume by 
40%59. In an analogous way, beta blockers reduced brain edema 
in a histological model of traumatic brain injury60. Positive effects 
of beta blockade on outcome have also been reported in patients 
with traumatic brain injury61, 62.
The use of beta blockers in acute human stroke may 
appear controversial. Atenolol and propranolol tested in a 
randomized, controlled study of 302 acute stroke patients showed 
a trend toward increased death and disability in the treatment 
group63. Through negative inotrope activity, beta blockers may 
potentially reduce global cerebral blood flow. However, other 
studies did not demonstrate any harmful effect of beta blockers in 
acute stroke; on the contrary, possible neuroprotective properties 
have been advocated64, 65, 66.  Clonidine, moxonidine, and 
mecobalamin may also improve baroreflex sensitivity. A central 
mechanism of action is supposed in the effects of clonidine and 
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moxonidine, whereas a peripheral mechanism is suggested for 
mecobalamin67, 68. Clonidine was also shown to increase the 
activity of baroreceptive neurons in the ventrolateral medulla, 
enhance the slope of the cardiac baroreflex, and reduce pressure 
lability69. 
New devices stimulating baroreceptors are emerging in 
the treatment of chronic refractory hypertension. Mediated through 
the central sympathoinhibitory effect by stimulating the carotid 
baroreceptors electrically, these devices ameliorate baroreflex 
sensitivity and reduce hypertension. On-going trials on these 
devices are finding significant and sustained reductions in blood 
pressure, a good safety profile, and tolerable side effects70. 
However, the evidence is insufficient to draw further conclusions, 
in particular regarding acute stroke therapy.
AUTONOMIC FUNCTION TESTING
With the evolution and validation of reliable non-invasive 
techniques, the evaluation of autonomic disorders is more widely 
available. Numerous techniques to evaluate autonomic functions 
had been described, of which cardiovagal, adrenergic and 
sudomotor functions are most common methods involved. This 
study is done by testing the cardiac autonomic functions. Though 
the pathogenesis of cerebrovascular diseases involves the central 
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nervous system, appropriateness of studying the cardiac 
autonomic regulation as a replacement for examining the cerebral 
autonomic regulation is supported by several studies. 
Zvan et al while examining the effects of activation of 
sympathetic nervous system in rats found an increase in heart rate 
and mean blood velocity in the middle cerebral artery suggesting 
that autonomic dysregulation that affected cardiac function also 
affected the cerebral vascular activity71. Therefore it appears 
appropriate that the study of cardiac autonomic nervous system 
will be closely associated with cephalic vasomotor response.
For diagnostic purpose it is preferable to perform a 
battery of tests rather than to rely on single test to determine the 
intactness of autonomic reflex72. The most commonly used test of 
autonomic function relies on heart rate and blood pressure 
changes in response to breathing, and to posture changes. These 
tests are simple, non-invasive, easy to perform & reproduce, and 
are both sensitive as well as specific73. 
The following tests are usually carried out to assess the 
Autonomic Nervous System functioning namely Heart rate 
response to deep breathing, Heart rate response to Valsalva 
manoeuvre, Heart rate response to standing (30:15 ratio), Beat to 
beat BP response to Valsalva manoeuvre during phase IV, Heart 
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rate and BP response to active standing, Diastolic BP and heart 
rate response during cold pressor test, BP and heart rate response 
during and after 5 minutes of isometric hand grip test. However 
these are not feasible in a patient afflicted with stroke because of 
his debilitation or because of technical restrictions. Hence it 
becomes paramount to ascertain a more suitable and non-invasive 
method of assessment of autonomic function in these patients
Sztajzel et al have stated that among the different 
available non-invasive techniques for the assessment of 
autonomic status, heart rate variability has emerged as a simple 
non-invasive method to evaluate sympathovagal balance at the 
sino-atrial node74. 
HEART RATE VARIABILITY
The intrinsic firing rate of uninnervated human sinoatrial 
node (SA) is 100 beats per minute. In an innervated heart the 
sympathetic system will increase the rate of depolarization of 
sinoatrial node, while parasympathetic innervation supplied by
vagus nerve decreases the firing rate of sinoatrial node. The net 
accelerating and decelerating influences of the cardiac 
sympathetic and parasympathetic system will determine the 
cardiac sympathetic tone and cardiac parasympathetic tone. The 
predominance of resting vagal tone over sympathetic tone is 
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responsible for heart rate below 100. The heart rate is 
conventionally measured by noting the number of heart beats per 
minute. The duration of cardiac cycle of all heart beats occurring in 
one minute, even under resting condition is not the same. There is 
beat to beat variability of RR interval in milliseconds. This 
spontaneous beat to beat variation is known as HEART RATE 
VARIABILITY (HRV).
Donald Moss & Fred Shaffer aptly described that “The 
human heart is a bioelectrical pump, beating at ever changing rate: 
it is not like a clock that beats at a steady unchanging rate”. The 
sympathetic activity will decrease the RR interval and 
parasympathetic will increase the RR interval. So heart rate 
variability can be used as one of the non-invasive tests to evaluate 
the integrity and functional state of Autonomic Nervous System.
The assessment of Heart rate variability has undergone a 
remarkable sea of change from the early days when it was first 
demonstrated by Hon and Lee in the year 196575. With the 
availability of new, digital, high frequency, 24-h multi-channel 
electrocardiographic recorders, the significance and meaning of 
the many different measures of Heart Rate Variability became 
more complex. There arose a potential for incorrect conclusions 
and for excessive or unfounded extrapolations. The recognition of 
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these problems led the European Society of Cardiology and the 
North American Society of Pacing and Electrophysiology to 
constitute a Task Force charged with the responsibility of 
developing appropriate standards. The task force came out in 
1996 with the “Heart rate variability Standards of measurement, 
physiological interpretation, and clinical use Guidelines76”. 
The heart rate variability can be assessed with the use of 
time domain methods or frequency domain methods as per the 
guidelines.
TIME DOMAIN METHODS
The time domain methods measure either the heart rate 
at any point in time or the intervals between successive normal 
complexes. From these measurements simple time–domain 
variables that can be calculated include the mean NN interval, the 
mean heart rate, the difference between the longest and shortest 
NN interval and the difference between night and day heart rate. 
From a series of instantaneous heart rates or cycle intervals, 
particularly those recorded over longer periods, traditionally 24 h, 
more complex statistical and geometric time-domain measures 
can be calculated. 
The statistical time domain measures may be divided into 
two classes, (a) those derived from direct measurements of the 
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NN intervals or instantaneous heart rate, and (b) those derived 
from the differences between NN intervals. They include:
a) SDNN – Standard deviation of all NN intervals 
(measured in ms).
b) SDANN – Standard deviation of the averages of NN 
intervals in all 5 min segments of the entire recording 
(measured in ms).
c) RMSSD – The square root of the mean of the sum of 
the squares of differences between adjacent NN 
intervals (measured in ms).
d) SDNN index – Mean of the standard deviations of all 
NN intervals for all 5 min segments of the entire 
recording (measured in ms).
e) SDSD – Standard deviation of differences between 
adjacent NN intervals (measured in msec).
f) NN50 count – Number of pairs of adjacent NN intervals 
differing by more than 50 ms in the entire recording. 
Three variants are possible counting all such NN 
intervals pairs or only pairs in which the first or the 
second interval is longer.
g) pNN50% – It is the NN50 count divided by the total 
number of all NN intervals.
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In general, the statistical time domain methods are more 
likely to deliver a better assessment of the autonomic function 
when assessed over a longer period of 24 hours rather than short 
term recordings of 5 minutes.
The geometrical time domain measures are derived by converting 
the series of NN intervals into a geometric pattern and analysing 
them. They include:
a) HRV triangular index – Total number of all NN intervals 
divided by the height of the histogram of all NN intervals 
measured on discrete scale with bins of 7·8125 ms (1/128 s).
b) TINN – Baseline width of the minimum square difference 
triangular interpolation of the highest peak of the histogram 
of all NN intervals (measured in ms).
c) Differential index – Difference between the widths of the 
histogram of differences between adjacent NN intervals 
measured at selected heights (e.g. at the levels of 1000 and 
10 000 samples) (measured in ms)
d) Logarithmic index Coefficient φ of the negative exponential 
curve k·e-φt which is the best approximation of the histogram 
of absolute differences between adjacent NN intervals.
The major advantage of geometric methods lies in their 
relative insensitivity to the analytical quality of the series of NN 
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intervals. The major disadvantage is the need for a reasonable 
number of NN intervals to construct the geometric pattern. In 
practice, recordings of at least 20 min (but preferably 24 h) should 
be used to ensure the correct performance of the geometric 
methods, i.e. the current geometric methods are inappropriate to 
assess short-term changes in HRV76.
FREQUENCY DOMAIN METHODS
Various spectral methods for the analysis of the 
tachogram have been applied since the late 1960s. Power 
Spectral Density analysis provides the basic information of how 
power (i.e. variance) distributes as a function of frequency.
Methods for the calculation of Power Spectral Density 
may be generally classified as non-parametric and parametric. In 
most instances, both methods provide comparable results. The 
advantages of the non-parametric methods are: (a) the simplicity 
of the algorithm employed (Fast Fourier Transform – FFT) and (b) 
the high processing speed, whilst the advantages of parametric 
methods are: (a) smoother spectral components which can be 
distinguished independently of preselected frequency bands, (b) 
easy post-processing of the spectrum with an automatic 
calculation of low and high frequency power components and easy 
identification of the central frequency of each component, and (c) 
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an accurate estimation of PSD even on a small number of samples 
on which the signal is supposed to maintain stationarity. The basic 
disadvantage of parametric methods is the need to verify the 
suitability of the chosen model and its complexity.
Among short term recordings of 5 minutes duration, three 
main spectral components are distinguished.
 Very low frequency (VLF) [Range ≤ 0.04Hz]
 Low frequency (LF) [Range 0.04 – 0.15 Hz] and
 High frequency (HF) [ Range 0.15 – 0.40 Hz]
The distribution of the power and the central frequency of LF and 
HF are not fixed but may vary in relation to changes in autonomic 
modulations of the heart period. The physiological explanation of 
the VLF component is much less defined and the existence of a 
specific physiological process attributable to these heart period 
changes might even be questioned. The non-harmonic component 
which does not have coherent properties and which is affected by 
algorithms of baseline or trend removal is commonly accepted as 
a major constituent of VLF. Thus VLF assessed from short-term 
recordings of 5 min is a dubious measure and should be avoided 
when interpreting the Power Spectral Density of short-term 
recordings.
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Measurement of VLF, LF and HF power components is 
usually made in absolute values of power (ms2), but LF and HF 
may also be measured in normalized units (n.u.) which represent 
the relative value of each power component in proportion to the 
total power minus the VLF component. The representation of LF 
and HF in n.u. emphasizes the controlled and balanced behaviour 
of the two branches of the autonomic nervous system. Moreover, 
normalization tends to minimize the effect on the values of LF and 
HF components of the changes in total power76.
REQUIREMENTS FOR RECORDING
a) ECG SIGNAL
The fiducial point recognised on the ECG tracing which 
identifies a QRS complex may be based on the maximum or 
baricentrum of the complex, on the determination of the maximum 
of an interpolating curve, or found by matching with a template or 
other event markers. A limited sampling rate induces an error in 
the HRV spectrum which increases with frequency, thus affecting 
more high frequency components. Hence a higher sampling rate is 
preferable.
b) DURATION OF ECG RECORDING
Frequency–domain methods should be preferred to the 
time–domain methods when investigating short term recordings. 
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The recording should last for at least 10 times the wavelength of 
the lower frequency bound of the investigated component, and, in 
order to ensure the stability of the signal, should not be
substantially extended. Thus, recording of approximately 1 min is 
needed to assess the HF components of heart rate variability while 
approximately 2 min are needed to address the LF component. In 
order to standardize different studies investigating short-term HRV, 
5 min recordings of a stationary system are preferred unless the 
nature of the study dictates another design. Although the time–
domain methods, especially the SDNN and RMSSD methods, can 
be used to investigate recordings of short durations, the frequency 
methods are usually able to provide more easily interpretable 
results in terms of physiological regulations. In general, the time–
domain methods are ideal for the analysis of long-term recordings
c) EDITING OF THE RR INTERVAL SEQUENCE
The errors imposed by the imprecision of the NN interval 
sequence are known to affect substantially the results of statistical 
time domain and all frequency domain methods. It is known that 
casual editing of the RR interval data is sufficient for the 
approximate assessment of total HRV by the geometric methods, 
but it is not known how precise the editing should be to ensure 
correct results from other methods. Thus when using the statistical 
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time domain and/or frequency domain methods, the manual 
editing of the RR data should be performed to a very high standard 
ensuring correct identification and classification of every QRS 
complex. Automatic ‘filters’ which exclude some intervals from the 
original RR sequence (e.g. those differing by more than 20% from 
the previous interval) should not replace manual editing as they 
are known to behave unsatisfactorily and to have undesirable 
effects leading potentially to errors76.
INTERPRETATION OF COMPONENTS
Vagal activity is the major contributor to the HF 
component. Disagreement exists in respect of the LF component. 
Some studies suggest that LF, when expressed in normalized 
units, is a quantitative marker for sympathetic modulations, other 
studies view LF as reflecting both sympathetic and vagal activity. 
Consequently, the LF/HF ratio is considered by some investigators 
to mirror sympathovagal balance or to reflect sympathetic 
modulations. Physiological interpretation of lower frequency 
components of HRV (that is of the VLF and ULF components) 
warrants further elucidation.
It is important to note that heart rate variability measures 
fluctuations in autonomic inputs to the heart rather than the mean 
level of autonomic inputs. Thus both autonomic withdrawal and a 
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very high level of sympathetic input lead to diminished heart rate 
variability76.
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PATIENTS AND METHODS
The present study was a prospective, controlled, open-label 
study carried out between May and November 2011 on patients 
who were admitted to the Rajiv Gandhi Government General 
hospital, Chennai, a tertiary care referral hospital which caters to 
the needs of the population of Tamilnadu and those from 
neighbouring states such as Andhra Pradesh and Karnataka with 
a clinical diagnosis of acute cerebrovascular disease. The protocol 
of the study was approved by the Institutional Ethics Committee, 
Madras Medical College Chennai 600003 and detailed informed 
written consent was obtained prior to enrolment in the study either 
from the patient (if possible) or else from the legal guardian of the 
patient.
STUDY POPULATION
One hundred (100) patients admitted to the various medical 
wards of Rajiv Gandhi Government General Hospital, Chennai 
were enrolled for the present study.
INCLUSION CRITERIA
The following were the criteria for enrolment in the present 
study: 
a) Age : Above 18 years
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b) Sex : Either sex 
c) In patient/Outpatient: In-patient
d) Clinical diagnosis : Acute Cerebrovascular Disease 
(defined as onset of the symptoms less than 7 days) as 
confirmed by clinical and/or radiological evidence of 
neurological deficit(s)
EXCLUSION CRITERIA
The following groups of patients were excluded from the 
study. 
a) Patients with history of established cerebrovascular accident
b) Patients with established intra-cardiac conduction defects 
which could interfere with the interpretation of results
c) Patients with advanced hepatic, renal or cardiovascular 
diseases which precluded their enrolment in to the study due 
to the critical nature of their comorbid illnesses.
d) Pregnant or lactating women
e) Those who were unwilling to sign the informed written 
consent
After obtaining written informed consent, a single investigator 
interviewed and evaluated all the patients with necessary help 
from the nursing staff as required. Relevant demographic data 
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required for identification purposes, were sought. A semi 
structured questionnaire (Appendix A), which was prepared 
earlier was administered by the Principal Investigator of the study. 
All the relevant information obtained by the interview, examination, 
investigation and evaluation of the patient were filled in by the 
Principal Investigator of the study.
The blood pressure was recorded with a mercury 
Sphygmomanometer in the supine position in all patients after 
ensuring that they had remained in the same position for at least a 
minimum of five minutes. A total of three readings were obtained 
from the arm which was not involved and the lowest of the three 
was taken for entry in to the study.
The severity of the stroke was established using the NIHSS-
National Institute of Health Stroke Scale (Appendix B). 
RECORDING OF ELECTROCARDIOGRAM FOR ANALYSIS
ECG tracings were obtained using NIVIQURE Ambulatory 
Digital ECG Recorder (INCO). All patients who were conscious 
and ambulant were instructed to empty their bladders prior to the 
recording. In patients who were unconscious or not ambulant, a 
sterile catheterisation of the urinary bladder was performed in the 
usual way and connected to a urinary bag and urine was drained. 
All patients were allowed to rest in the supine position for five 
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minutes in a calm and isolated room in the wards. After five 
minutes, the electrodes were placed on the chest in the Right 
infraclavicular, Left infraclavicular, Right inguinal and Left inguinal 
regions. The electrodes were connected to the recording machine 
and through the machine to the computer for recording the 
electrocardiogram. The recorder was precalibrated to the following 
settings to ensure uniformity in the recordings. The sampling rate 
was set to 1024 Hz and the recording interval was set to 320 sec 
(5min = 300 sec with 10 sec lead in and 10 sec lead out period). 
The machine was turned on and the recording was done with the 
patient remaining in the same posture throughout the entire period 
of the study.
At the end of the time window, the electrodes were 
disconnected and the recording was transferred to the computer. 
The recorded data was screened for the presence of artefacts and 
appropriately edited according to guidelines to ensure the validity 
of the result. The edited data was opened through the Heart Rate 
Variability Analysis Software (version 1.1, Biomedical Signal 
Analysis Group, Department of Applied Physics, University of 
Kuopio, Finland) and analysed. Power spectral analysis of the data 
was done using the Fast Fourier Transformation algorithm and the 
power of the very low frequency (VLF), low frequency (LF) and 
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high frequency (HF) bands were noted down. The ratio of LF to HF 
(LF/HF) was calculated by the software and the value was also 
noted.
Relevant basic laboratory investigations including complete 
blood count, renal parameters andblood sugar were undertaken 
from a single sample of blood taken at the time of admission. The 
findings from a relevant radiological investigation either CT Brain 
Plain or MRI Brain with MRA / MRV were included in the study 
depending on the investigation done for the patient. A baseline 
Electrocardiogram was also done in the supine position to rule out 
the presence of any conduction abnormalities in the patient
The patient was followed up during their period of stay in the 
hospital and the outcome was noted as either survived or died at 
the end of their stay in the hospital.
STATISTICAL ANALYSIS
The data collected from the patients were entered in to the 
master chart prepared. The statistical analysis was done using 
Graphpad Prism version 5. For non-parametric data, Chi square 
test was used. For parametric data, student’s t-test or ANOVA 
(ANalysis of One way VAriance) was done as deemed appropriate 
to the data of interest.
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OBSERVATIONS
AGE/ SEX DISTRIBUTION
The study involved a total of 100 (hundred) patients. The 
demographic characteristics of the enrolled subjects are presented 
in Table 1 and 2. Of the whole study population, there were 57 
males and 43 females with an age range of 26 to 93 years. The 
age group distribution (Fig.1.) indicated that the major brunt of the 
illness was felt by the patients in the age group 55 to 75 years. A 
majority of patients affected among the study population were 
male (Fig.2).
Table 1: Age group distribution
AGE GROUP NO of PATIENTS
25-34 4
35-44 8
45-54 17
55-64 29
65-74 26
75-84 12
85+ 4
Table 2: Sex distribution
SEX DISTRIBUTION
Male 57
Female 43
Figure 1: Age group distribution of the study population
Figure 2: Sex distribution of the study 
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Risk factors for stroke
Diabetes and Hypertension
Twenty seven (47.36%) of the male patients had a history of 
type 2 diabetes mellitus while among female patients it was only 
39.53% (n=17). Similarly twenty six of the male patients had 
systemic hypertension while 45.6% of the female patients had 
systemic hypertension. Only 26.13 % of males (n=15) and 22.73% 
of females (n=10) did not have any of the above risk factors. 
Table 3: Risk factor distribution
RISK FACTOR MALE FEMALE
Diabetes Mellitus (DM) 16 7
Systemic Hypertension (SHT) 15 16
DM + SHT 11 10
None 15 10
Smoking and alcoholism
Among the females, there was only one alcoholic and no 
smoker. Among the males, 52.36% (n=30) accepted that they 
were active smokers while an equal number were found to be 
having an active alcohol habit. 28.07% (n=14) of the males had a 
combined habit. Only 22.81% (n=13) of the males did not have any 
habit.
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Table 4: Risk factor distribution
RISK FACTORS Alcoholism Smoking Both None
Males 14 14 16 13
Females 1 0 0 42
DETAILS OF STROKE 
Day of presentation to the hospital
The day patients presented themselves to the hospital ranged 
from Day 1 to Day 7 after having been treated at various centres. 
Thirty six patients presented to the hospital within 48 hours of 
onset of symptoms whereas a nearly equal number, 37 of them, 
presented to the hospital more than 96 hours after the onset of 
symptoms. 
Table 5: Day of Presentation to the hospital
DAY OF PRESENTATION No of PATIENTS
DAY 1 17
DAY 2 19
DAY 3 15
DAY 4 12
DAY 5 10
DAY 6 13
DAY 7 14
Figure 3: Prevalence of Diabetes and Hypertension 
Figure 4: Prevalence of Risk factors among males study 
54
subjects
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LESIONS INVOLVED
Infarcts/ haemorrhages
There was a large preponderance of arterial infarcts when 
compared to the haemorrhages (Fig 5). Only 23 patients had an 
intracerebral bleed whereas 77 of them had arterial infarcts (Table 
6). 
Arterial involvement
The middle cerebral artery (MCA) territory was most 
commonly involved (Fig 6) with 78 patients having either an infarct 
or haemorrhage there. While posterior circulation was involved in 
18 patients, only 4 patients had involvement of anterior cerebral 
artery territory (Table 7). 
Right vs. Left side 
Forty six of the patients had involvement of the right side and 
forty eight patients had involvement of the left side while only six 
patients had bilateral involvement (Table 8). Among the patients 
with MCA territory involvement, 35 had right sided involvement 
while 43 patients had left sided involvement (Fig. 8).
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Table 6: Lesion identified by radiological investigation
TYPE OF LESION PATIENTS
Haemorrhage 23
Infarct 77
Table 7: Arterial territory involvement
ARTERIAL TERRITORY PATIENTS
Anterior Cerebral Artery 4
Middle Cerebral Artery 78
Posterior Circulation 18
Table 8: Side involvement
SIDE OF LESION PATIENTS
Right side 46
Left side 48
Both sides 6
Figure 5: Lesion found by radiological investigation
Figure 6: Arterial Territory involved 
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Figure 7: Side of the Lesion
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IMPACT OF SYMPATHOVAGAL IMBALANCE
The impact of the presence of the sympathovagal imbalance 
was assessed by dividing the study population into two groups on 
the basis of the LF/HF ratio. One group (Group 1) included all the 
patients who had a LF/HF ratio above 1 and the other group 
(Group 2) included all the patients who had a LF/HF ratio less 
than 1. The following baseline characteristics were observed 
among the groups (Table 9).
Group 1 consisted of 63 patients while Group 2 had 37 
patients. The mean age was 63.21 ± 13.39 years in Group 1 while 
it was 57.59 ± 13.85 years in Group 2. Using the unpaired t test for 
difference between means, the difference was found to be 
statistically significant difference (P<0.05).
The mean duration of diabetes among the diabetics in the 
study population was 10.0 years (Range 0.0 – 25.0, n=30) in 
Group 1 against 6.71 years (Range 1.0 – 18.0, n=14).  Using the 
Mann Whitney test for difference between means of non-
parametric data, the difference was found to be statistically 
insignificant. The mean duration of hypertension among the 
hypertensives in the study population was 8.13 years (Range 1.0 –
25.0, n=29) in Group 1 against 6.50 years (Range 1.0 – 20.0, 
n=24) which was also not found to be statistically insignificant.
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Table 9: Baseline Characteristics of the study population
CHARACTERISTIC GROUP 1 GROUP 2 p value
Number of patients 63 37
Age (in years) 63.2 ± 13.4 57.6 ± 13.9 0.0485*
Duration of DM
(in years)
10.0 (0.0 – 25.0)
6.7 (1.0 –
18.0)
0.1574#
Duration of SHT
(in years)
8.1 (1.0 – 25.0)
6.5 (1.0 –
20.0)
0.0710#
Alcoholics(n) 23 8 0.1786#
Smokers(n) 20 10 0.6583#
Systolic BP
(mm Hg)
167.6 ± 25.4 148.5 ± 19.4 0.0002***
Diastolic BP
(mm Hg)
101.0 ± 18.9 88.8 ± 12.7 0.0007***
NIHSS Score 16.1 ± 8.3 11.5 ± 6.6 0.0045**
LF Power (n. u.) 63.05 ± 8.9 31.96 ± 10.6 <0.0001****
HF Power (n. u.) 35.33 ± 9.0 66.43 ± 10.1 <0.0001****
Survival(n) 38 31 0.0152*
* – SIGNIFICANT (p < 0.05), ** – VERY SIGNIFICANT (p<0.01), *** – HIGHLY 
SIGNIFICANT (p<0.001), **** – VERY HIGHLY SIGNIFICANT (p<0.0001), # – NOT 
SIGNIFICANT
Results are reported as Mean ± Standard deviation and as mean with range 
wherever applicable. Difference between means for parametric data was calculated 
using the student’s unpaired t-test with two tailed p value. Difference between means 
for non-parametric data was calculated using Mann-Whitney test with two tailed p 
value. Difference between proportions was calculated using Fisher’s exact test with 
two tailed p value.
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The proportion of alcohol use among the patients of Group 1 
was 36.51% (n = 23/63) against 21.62% (n = 8/37) in Group 2. 
When the difference was analysed for significance using the 
Fisher’s exact value test for proportions, the p value was found to 
be not statistically significant. The proportion of smoking among 
patients of Group 1 was 31.74% (n = 20/63) against 27.03 % (n = 
10/37) in Group 2 and this difference was also found to be not 
statistically significant.
The mean systolic blood pressure recorded among the 
patients of Group 1 was found to be 167.6 ± 25.36 mm Hg versus 
148.5 ± 19.42 mm Hg among the patients of Group 2 and this 
difference was highly significant (P < 0.001). The mean diastolic 
blood pressure recorded among the patients of Group 1 was found 
to be 101.0 ± 18.94 mm Hg versus 88.76 ± 12.66 mm Hg among 
the patients of Group 2 and this was also found to be highly 
significant (P < 0.001).
The mean National Institute of Health Stroke Scale score 
was found to be 16.14 ± 8.29 among patients of Group 1 while it 
was only 11.49 ± 6.63 which was also statistically very significant 
(P <0.01). The mean spectral power of the low frequency 
component among patients of Group 1 was 63.05 ± 8.90 and 
among patients of Group 2 it was 31.96 ± 10.59. The mean 
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spectral power of the high frequency component among patients of 
Group 1 was 35.28 ± 8.96 and among patients of Group 2 it was 
66.35 ± 10.12. Both the differences were statistically very highly 
significant with P<0.0001. The survival proportion was 60.32% 
(n=25/63) in Group 1 and 83.78% (n=6/37) in Group 2 and the 
difference was also found to be statistically significant (P<0.05).
IMPACT OF LATERALIZATION OF THE LESION
A total of 78 patients had lesions involving the middle 
cerebral artery territory. Among them, thirty five of them had 
lesions on the right side while forty three of them had lesions on 
the left side (Table 10).
The mean systolic blood pressure was higher among the 
patients with right sided involvement when compared to the 
patients with left sided involvement (164.9 ± 23.74 vs. 154.6 ± 
19.56 mm Hg) and this difference was statistically significant 
(P<0.05). The mean diastolic blood pressure and the mean NIHSS 
score among the two groups were however not statistically 
significant.
The mean spectral power of the low frequency 
component and the mean LF/HF ratio was higher among patients 
with right sided involvement while the mean spectral power of the 
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high frequency component was higher among the patients with left 
sided involvement. All these differences were statistically very 
highly significant (P<0.0001). However the survival proportions 
among the two groups was not statistically significant (65.71% 
among right sided lesions and 79.07% among left sided lesions).
TABLE 10: IMPACT OF RIGHT SIDE INVOLVEMENT VS. LEFT 
SIDE INVOLVEMENT AMONG PATIENTS WITH MIDDLE 
CEREBRAL ARTERY TERRITORY INVOLVEMENT
CHARACTER
RIGHT SIDE 
LESION
LEFT SIDE 
LESION
p value
No of Patients 35 43
Systolic BP
(mm Hg)
164.9 ± 23.7 154.6 ± 19.6 0.0389*
Diastolic BP
(mm Hg)
99.0 ± 17.1 93.0 ± 15.0 0.1034#
NIHSS Score 14.4 ± 6.4 13.8 ± 7.5 0.7017#
LF Power(n.u.) 61.2 ± 13.8 43.2 ± 17.3 <0.0001****
HF Power(n.u.) 37.4 ± 13.7 55.0 ± 17.2 <0.0001****
LF/HF ratio 2.0 ± 1.0 1.0 ± 0.8 <0.0001****
Survival(n) 23 34 0.2089#
* – SIGNIFICANT (p < 0.05), ** – VERY SIGNIFICANT (p<0.01), *** – HIGHLY 
SIGNIFICANT (p<0.001), **** – VERY HIGHLY SIGNIFICANT (p<0.0001), # – NOT 
SIGNIFICANT
Results are reported as Mean ± Standard deviation and as mean with range 
wherever applicable. Difference between means for parametric data was calculated 
using the student’s unpaired t-test with two tailed p value. Difference between means 
for non-parametric data was calculated using Mann-Whitney test with two tailed p 
value. Difference between proportions was calculated using Fisher’s exact test with 
two tailed p value.
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IMPACT OF THE TYPE OF LESION
In the one hundred patients studied, there was a 
predominance of infarcts, with only twenty three patients having a 
haemorrhagic lesion and the remaining seventy seven having an 
infarction (Table 11).
The mean systolic and diastolic blood pressures were much 
higher among the patients with haemorrhage when compared to 
patients with an infarction (178.20 ± 27.49 vs. 155.20 ± 21.75 and 
108.70 ± 19.34 vs. 92.81 ± 15.73 mm Hg) and this difference was 
statistically very highly significant (P < 0.0001).The mean NIHSS 
score was also higher among patients with haemorrhage when 
compared to those with infarctions, 20.48 ± 7.90 vs. 12.61 ± 7.14. 
This difference was also statistically very highly significant (P < 
0.0001).
The mean spectral power of the low frequency component 
and the mean LF/HF ratio was higher among patients with 
haemorrhage while the mean spectral power of the high frequency 
component was higher among the patients with left sided 
involvement. All these differences were statistically very highly
significant (P<0.0001). Also the survival proportions among the 
two groups was statistically very significant (43.48 %, n=10/23 
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among patients with haemorrhagic lesions and 76.62%, n=59/77 
among patients with infarcts) (P<0.01).
TABLE 11: IMPACT OF TYPE OF LESION AMONG ALL 
PATIENTS
CHARACTER INFARCTION HAEMORRHAGE p value
No of Patients 77 23
Systolic BP
(mm Hg)
155.2 ± 21.8 178.2 ± 27.5 <0.0001****
Diastolic BP
(mm Hg)
92.8 ± 15.7 108.7 ± 19.3 <0.0001****
NIHSS Score 12.6 ± 7.1 20.5 ± 8.0 <0.0001****
LF Power(n.u.) 48.7 ± 17.7 61.2 ± 15.1 0.0028***
HF Power(n.u.) 49.6 ± 17.5 37.3 ± 15.3 0.0031***
LF/HF ratio 1.3 ± 0.9 2.0 ± 1.1 0.0013***
Survival(n) 59 10 0.0043**
* – SIGNIFICANT (p < 0.05), ** – VERY SIGNIFICANT (p<0.01), *** – HIGHLY 
SIGNIFICANT (p<0.001), **** – VERY HIGHLY SIGNIFICANT (p<0.0001), # – NOT 
SIGNIFICANT
Results are reported as Mean ± Standard deviation and as mean with range 
wherever applicable. Difference between means for parametric data was calculated 
using the student’s unpaired t-test with two tailed p value. Difference between means 
for non-parametric data was calculated using Mann-Whitney test with two tailed p 
value. Difference between proportions was calculated using Fisher’s exact test with 
two tailed p value.
IMPACT ON SURVIVAL
The impact of the heart rate variability on the outcome of 
patients with acute cerebrovascular disease was also assessed
(Fig9). In patients who died, the mean power of the low frequency 
component and power of the high frequency component were 
higher and lower respectively and this difference was found to be 
statistically significant. The mean systolic and diastolic pressure 
and the NIHSS score were also statistically significant between the 
groups (Table 12). 
Figure 11
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TABLE 12: IMPACT OF HEART RATE VARIABILITY ON 
SURVIVAL
CHARACTER SURVIVED DIED p value
No of Patients 69 31
Systolic BP
(mm Hg)
155.4 ± 20.6 171. 9 ± 30.2 0.002**
Diastolic BP
(mm Hg)
91.9 ± 14.3 106.6 ± 20.9 <0.0001****
NIHSS Score 11.8 ± 6.4 20.2 ± 8.3 <0.0001****
LF Power(n.u.) 47.1 ± 17.6 61.4 ± 14.3 0.0001***
HF Power(n.u.) 51.2 ± 17.4 37.0 ± 146 0.0002***
LF/HF ratio 1.2 ± 0.9 2.0 ± 1.1 <0.0001****
* – SIGNIFICANT (p < 0.05), ** – VERY SIGNIFICANT (p<0.01), *** – HIGHLY 
SIGNIFICANT (p<0.001), **** – VERY HIGHLY SIGNIFICANT (p<0.0001), # – NOT 
SIGNIFICANT
Results are reported as Mean ± Standard deviation and as mean with range 
wherever applicable. Difference between means for parametric data was calculated 
using the student’s unpaired t-test with two tailed p value. Difference between means 
for non-parametric data was calculated using Mann-Whitney test with two tailed p 
value. Difference between proportions was calculated using Fisher’s exact test with 
two tailed p value.
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DISCUSSION
The present study carried out to assess the status of 
autonomic function of patients when admitted to a tertiary care 
referral hospital in public sector, to our knowledge,is the first of its 
kind in acute setting in this part of the world.The mean age (61.2 
years) of the patients enrolled in the present study is in line with 
that of the Trivandrum Stroke Registry, a population based 
survey(67 years77), and that of Feigin et al, from the review of data 
from fifteen population based stroke incidence studies (60.8 to 
75.3 years for males and 66.6 to 78.0 years for females78).
The disease prevalence peaked in the 7th decade of life with nearly 
one third of patients belonging to that age group. This is also 
similar to the findings reported by the Trivandrum Stroke 
Registry77.However the finding in the present study of 6% of the 
patients being less than 40 years of age was slightly higher than 
the figure of 3.8% reported by the Trivandrum Stroke 
Registry77and comparable to the findings of Das et al who reported 
a prevalence of 8.8% in another population based study from West 
Bengal79.There was a predilection of males in this study which was 
not in line with the findings of Trivandrum Stroke Registry which 
reported a slightly higher level of incidence among the females77.
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The prevalence of risk factors for stroke like diabetes mellitus, 
hypertension (53 vs. 83%), smoking and alcohol habit were much 
lower in this study population when compared to figures reported 
from population based survey carried out by the Trivandrum 
Stroke Registry77. The prevalence of hypertension was only 53% 
in this study whereas it was much higher at 83% in their study. 
This figure is however in line with the findings of Strong et al who 
estimated that hypertension caused 54% of stroke mortality in low-
income and middle-income countries80. Modifiable risk factors like 
smoking and alcohol continue to have a higher prevalence among 
patients with stroke and this is a necessary target of intervention if 
we were to reduce the morbidity and mortality associated with the 
disease in a developing country like India.
The study was carried out in a tertiary care referral hospital 
serving not only the entire state of Tamilnadu but also 
neighbouring areas in the states of Karnataka, Andhra Pradesh 
and Puducherry. The patients came to seek medical attention after 
a varying period of time. One third of patients sought medical 
attention within 48 hours of onset of symptoms whereas a nearly 
equal number sought medical attention only after 96 hours 
preferring to have a wait and watch policy for self-improvement of 
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symptoms. This finding stresses the need to educate the general 
population about the disease in general and the necessity to seek 
medical intervention at the earliest as timely medical help will 
definitely go a long way in reducing the morbidity and mortality 
associated with the disease.
There were a large number of cases with infarction on 
imaging studies when compared to haemorrhage. This figure is 
comparable to the findings of Das et al and Sridharan et al 77,79. It 
also lies within the range of 67.3% to 80.5% for infarction and 
slightly above the range of 6.5% to 19.6% as reported by Feiginet 
al78.The overall case fatality rate of 31%,especially withthe elderly 
above 75 years having more chances of dying, is in agreement 
with the findings of theTrivandrum Stroke Registry and the study 
by Feiginand co-workers. 78.
In order to assess the effect of the altered sympathovagal 
balance in patients with acute stroke, the patients were divided 
into two groups. As the low frequency component were usually 
indicative of the sympathetic function and the high frequency 
component of the parasympathetic function, it is assumed that 
patients with a LF/HF ratio above 1 have a predominance of the 
sympathetic discharges on the heart and those with a LF/HF ratio 
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below 1 have a predominance of parasympathetic discharges on 
the heart.
When compared in such a way, the patients with LF/HF ratio 
had a significantly higher systolic and diastolic blood pressure 
reflecting the effect of the sympathetic system on the blood 
pressure.  These patients also had a statistically significant higher 
NIHSS score, elevated low frequency power and decreased high 
frequency power. The patients with a higher value for the ratio had 
a statistically reduced survival advantage.
When the impact of lateralisation of the lesion in the middle 
cerebral artery territory was assessed, there was a definite and 
statistically significant difference in the sympathovagal balance. 
There was a higher level of sympathetic outflow when the lesions 
involved the right cerebral hemisphere. There was also a 
corresponding increase in the parasympathetic outflow whenever 
the lesions involved the left cerebral hemisphere. These findings 
are similar to those of Colivicchi et al who showed a statistically 
significant difference between the involvements of right and left 
insular cortexes81. Meyer et al reported that when the systolic and 
diastolic blood pressure and heart rate were recorded during the 
first five days after stroke, sympathetic activity was significantly 
higher in insular than in non-insular infarction with concomitantly 
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elevated cardiovascular parameters in insular stroke patients. 
They also reported that the pathological activation of the 
sympathetic nervous system was most excessive in patients with 
the stroke involving the right sided insular cortex which they said 
indicated a hemispheric lateralization in autonomic activity which is 
mediated by the right-sided insular cortex82. Sander et al also state 
that the insular cortex in particular has an important role in the 
genesis of the pathological activation of the sympathetic nervous 
system and that the mechanism of cardiovascular instability 
following stroke relates to the loss of inhibition of the insular cortex 
and a reacting augmentation of the sympathetic tone. They also go 
on to state that sympathetic activation is lateralized following 
hemispheric brain infarction and accordingly, patients with a right-
sided hemispheric infarction show a significantly diminished 
circadian blood pressure variation as compared with patients with 
left-sided hemispheric infarction. They also found that hemispheric 
lesions were associated with a significantly higher incidence of 
cardiac arrhythmias83.
These findings have also been well established in 
experimental animal models of ischemia by Cechettoet al84. 
Oppenheimer et al demonstrated that the rat posterior insular 
cortex possesses cardiac chronotropic organization and therefore 
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may be involved in cortical mechanisms of sudden death when 
involved by lesions85.
However these findings were however not supported by 
Korpelainen et al who do not accept the effect of lateralisation of 
the cortical lesion on the heart rate variability86. Barron et al also 
demonstrated that the heart rate variability can be influenced by 
lesion on both sides39.
In a recent study by Hilz et al, the NIHSS score was found to  
correlate with the heart rate variability with a higher score leading 
to an increasing stroke severity was associated with progressive 
loss of overall autonomic modulation, decline in parasympathetic 
tone, and baroreflex sensitivity, as well as progressive shift toward 
sympathetic dominance. They also found that all autonomic 
changes put patients with more severe stroke at increasing risk of 
cardiovascular complications and poor outcome and that NIHSS 
scores are suited to predict risk of autonomic dysregulation and 
can be used as premonitory signs of autonomic failure87. In a study 
by Pradhan et al from NIMHANS, they found that HRV 
measurements are independent predictors of outcome in acute 
severe stroke88. 
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Korpelainen et al found that the distorted heart rate variability 
is related to a poor outcome in patients with acute hemispheric 
brain infarction and suggest that the monitoring of the dynamics of 
heart rate variability might be a useful indicator of the outcome of 
cerebral infarction in the future86.
The overall case fatality rate was 31% which the elderly 
above 75 years having more chances of dying. The case fatality of 
total strokes in Trivandrum Stroke Registry was 27.2%77. The 
figures from this study also did not vary beyond the range of 17% 
to 33% noted by Feiginet al78. The long term mortality is also 
higher in this population than the general population with a greater 
than two-fold relative risk of death for those patients surviving 
beyond 30 days as established by Hankey et al from the Perth 
Community Stoke Study89. They also found that the majority of 
deaths beyond 30 days are caused by non-stroke related events, 
in particular cardiac death89. The one year fatality rate is 31% for 
cerebral infarction and 37% for all-stroke causes as found by Thrift 
et al90. From the Dutch TIA Trial Study, sudden death accounted 
for 43% of serious cardiac events (death or nonfatal myocardial 
infarction) during long-term follow up of patients after transient 
ischemic attack or minor stroke91.
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It has also been clearly established that abnormal 
autonomic control, measured by heart rate variability, is an 
independent predictor of death after myocardial infarction13, 92. 
Reduced heart rate variability has been consistently associated 
with increased risk of cardiac and overall mortality, and it is 
hypothesized that this is because of sudden arrhythmic death 
caused by autonomic imbalance93.
The study has established that Heart Rate Variability is a 
strong predictor for mortality in patients with acute stroke and has 
a role in the assessment of every stroke patient and it reiterates 
the fact that routine evaluation of autonomic functions is 
mandatory in every stroke patient.
78
CONCLUSIONS
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CONCLUSIONS
Thefollowing conclusions are made from this study
1. There is a strong association between heart rate variability 
and poor short term both ischemic and haemorrhagic stroke
2. There is a strong association between right sided middle 
cerebral artery territory stroke and increased sympathetic 
discharges
3. There is a strong association between left sided middle 
cerebral artery territory stroke and increased 
parasympathetic discharges
4. There is a strong association between increase in the 
sympathetic dischargesand haemorrhagic lesions.
The role of the right sided cortical lesions in influencing 
the sympathetic tone has been established. However the exact 
mechanisms by which autonomic derangement affects outcome 
have not yet been clearly elucidated and the proposed 
underlying mechanisms are so far mostly speculative with 
definitive evidence in human beings still lacking. To elucidate 
the clinical implications of this finding more studies involving 
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more number of patients are warranted. Interventions directed 
towards addressing the sympathovagal imbalance has been 
validated in conditions like post myocardial infarction patients 
and heart failure patients. Whether similar interventions directed 
at rectifying the altered sympathovagal balance by 
pharmacological or other mechanisms can change the course 
of acute stroke and whether they can translate into patient 
benefits remains to be elucidated by further studies. 
Nevertheless, it seems that heart rate variability should 
definitely become a therapeutic target in future acute stroke 
research.
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